Phase 1b Study
A Phase 1 Study of AP02 (Nintedanib Solution for Inhalation) Delivered via the PARI eFlow® Nebulizer System to Evaluate the Safety, Tolerability, and Pharmacokinetics of AP02 in Healthy Volunteers
Phase 2b MIST Study
A Phase 2b Study Evaluating the Safety and Efficacy of AP01 (inhaled pirfenidone) in Participants With Progressive Pulmonary Fibrosis (PPF)
Learn more about MIST PPF Study